Tick-Borne Encephalitis (TBE) and Hepatitis B Nonresponders Feature Different Immunologic Mechanisms in Response to TBE and Influenza Vaccination with Involvement of Regulatory T and B Cells and IL-10
Open Access
- 1 September 2013
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 191 (5) , 2426-2436
Abstract
Low responsiveness/nonresponsiveness is characterized by an insufficient immune response upon primary and/or booster vaccination and affects 1–10% of vaccinees. In the current study, we aimed to investigate whether nonresponsiveness is an Ag/vaccine-specific phenomenon and to clarify underlying immunological mechanisms. Nonresponders to tick-borne encephalitis (TBE) or hepatitis B Ag with a history of previous TBE vaccinations were booster vaccinated with TBE and influenza vaccine and compared with TBE high responders in terms of humoral and cellular immune response. Postboosters in TBE high responder existing TBE titers increased, and solid humoral responses to influenza vaccine were induced. In TBE nonresponders, low to undetectable prevaccination TBE titers remained low, whereas sufficient influenza Abs were induced. In both TBE groups, a positive correlation of humoral and cellular immune response was seen as high/low TBE titers were associated with sufficient/lack of Ag-specific T cell proliferation. Furthermore, responses to influenza were robust in terms of Abs and cytokine production. In contrast, in hepatitis B nonresponders, sufficient humoral responses to TBE and influenza Ags were induced despite lacking specific IL-2 and IFN-γ production. Importantly, these patients showed high IL-10 baseline levels in vitro. HLA-DR subtypes associated with hepatitis B nonresponsiveness were overrepresented in this group, and high IL-10 levels were linked to these subtypes. Whereas TBE and hepatitis B nonresponders had increased IL-10–producing FOXP3+ T regulatory cells upon vaccination, only in hepatitis B nonresponders, showing elevated prevaccination IL-10 levels, a prominent population of B regulatory cells was detected. We conclude that immunological pathways of nonresponsiveness follow different patterns depending both on vaccine Ag and genetic predisposition of the vaccinee.Keywords
This publication has 44 references indexed in Scilit:
- Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccineesVaccine, 2009
- Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study populationVaccine, 2007
- A Functional Polymorphism in the IL - 10 Promoter Influences the Response After Vaccination With HBsAg and Hepatitis A *Hepatology, 2005
- Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccinesJournal of Medical Virology, 2005
- Most humoral non-responders to hepatitis B vaccines develop HBV-specific cellular immune responsesVaccine, 2004
- TBE vaccination and the Austrian experienceVaccine, 2003
- Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccinesJournal of Medical Virology, 2000
- Hepatitis B third‐generation vaccines: improved response and conventional vaccine non‐response – evidence for genetic basis in humansJournal of Viral Hepatitis, 1998
- Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule)Acta Tropica, 1998
- German experimental hepatitis B vaccine — Influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workersJournal of Molecular Medicine, 1986